November 18, 2014
Want to travel to Mars? Bring empathy, communication skills; expect trouble with seeing, thinking—and keeping food down.
November 11, 2014
Studies suggest amyloid accumulates for 3
decades or more before dementia symptoms show.
October 28, 2014
Researchers are teasing out brain areas and networks that respond to threats, real and imagined.
October 21, 2014
Discovery that the fluid between brain cells acts as sewer lines while we sleep has some researchers theorizing that we might find biomarkers that could predict diseases at a much earlier stage.
October 14, 2014
Researchers, doctors, and patients await the results of the first clinical trial to prevent Alzheimer’s in ordinary elderly people.
October 7, 2014
Learning false information when sleepy can change a person’s memory of a photograph, researchers find.
September 23, 2014
new insights into how the tau protein spreads within and harms the brain, in
Alzheimer’s and other diseases--and tau-targeting therapies are now entering
September 15, 2014
Dementias, ALS, and Huntington’s show different outward symptoms, but researchers theorize the disease process may be similar—a buildup of proteins that normally are cleared away.
August 27, 2014
Lower vitamin D levels linked to higher dementia risk in two separate studies.
August 25, 2014
discussed the molecular mechanisms linking sleep to depression and stress at
the 9th FENS Forum of Neuroscience in Milan last month.
August 21, 2014
Approaches include stimulating the growth of nerve fibers to
improve sound perception and scanning the cortex to improve the device’s
August 18, 2014
links between impaired hearing and loss of cognitive abilities raise the
tantalizing possibility that restoring hearing could slow cognitive decline.
August 11, 2014
Researchers focusing on glutamate pathways may have found a potential biomarker for the mood disorder.
Page: 1 of 40
July 24, 2014
Stem Cell Transplants Show Promise for Future Parkinson’s Treatments
Parkinson's disease is a debilitating neurodegenerative disorder that targets dopaminergic cells in an area of the brain called the substantia nigra. Most patients are treated with the drug Levodop